Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | CMPX | RENB | ||
| Company | Lineage Cell Therapeutics Inc | Compass Therapeutics Inc | Renovaro Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 1.1200 | 1.6700 | 1.5000 | ||
| High | 1.1200 | 1.6900 | 1.5800 | ||
| Low | 1.0400 | 1.6200 | 1.4200 | ||
| Last | 1.0500 | 1.6500 | 1.4900 | ||
| Change | -0.0800 | +0.0800 | +0.0200 | ||
| % Change | -7.08% | +5.10% | +1.36% | ||
| Volume | 1,838,900 | 475,500 | 217,300 | ||
| 20-Day Average Volume | 849,330 | 350,280 | 331,150 | ||
| Previous Close | 1.1300 | 1.5700 | 1.4700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2195 | 1.5535 | 2.1360 | ||
| 20-Day Raw Stochastic | 2.33% | 68.09% | 14.45% | ||
| 20-Day Relative Strength | 42.19% | 49.35% | 31.45% | ||
| Weighted Alpha | -28.13 | -48.93 | -43.51 | ||
| Today's Opinion | 24% Sell | 56% Sell | 88% Sell | ||
| Previous Opinion | 8% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 16% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.41% since 04/25/24 | +11.49% since 04/25/24 | -12.35% since 04/25/24 | ||
| Low | 1.0400 on 05/02/24 | 1.4000 on 04/29/24 | 1.2400 on 04/29/24 | ||
| High | 1.1700 on 04/29/24 | 1.6900 on 05/02/24 | 2.1000 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -25.00% since 04/02/24 | -8.33% since 04/02/24 | -47.16% since 04/02/24 | ||
| Low | 1.0400 on 05/02/24 | 1.3300 on 04/25/24 | 1.2400 on 04/29/24 | ||
| High | 1.5600 on 04/04/24 | 1.9300 on 04/04/24 | 2.9700 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +7.14% since 02/02/24 | +35.25% since 02/02/24 | -66.06% since 02/02/24 | ||
| Low | 0.9901 on 02/05/24 | 1.1500 on 02/05/24 | 1.2400 on 04/29/24 | ||
| High | 1.6100 on 03/28/24 | 2.3400 on 03/15/24 | 4.4500 on 02/06/24 | ||
| 6-Month | |||||
| %Chg | -7.08% since 11/02/23 | -10.33% since 11/02/23 | -51.15% since 11/02/23 | ||
| Low | 0.8414 on 02/01/24 | 1.1500 on 02/05/24 | 1.2400 on 04/29/24 | ||
| High | 1.6100 on 03/28/24 | 2.3400 on 03/15/24 | 5.2500 on 01/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 213,342 | 216,015 | 211,192 | ||
| Shares Outstanding, K | 188,798 | 137,589 | 143,668 | ||
| Annual Sales | 8,950,000 | 0 | 0 | ||
| Annual Net Income | -21,490,000 | -42,490,000 | -39,680,000 | ||
| Last Quarter Sales | 2,090,000 | 0 | 0 | ||
| Last Quarter Net Income | -4,780,000 | -13,420,000 | -4,530,000 | ||
| 60-Month Beta | 1.39 | 0.92 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 03/07/24 | -0.11 on 03/21/24 | -0.07 on 02/14/24 | ||
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/10/24 | ||
| Most Recent Dividend | 0.080 on 12/15/03 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||